[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-339876-105":59,"doc-detail-339876-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","single-cell-transcriptome-profiles-the-heterogeneity-of-tumor-cells-and-microenvironments-for-different-pathological-endometrial-cancer-and-identifies-specific-sensitive-drugs","Single-cell transcriptome proﬁles the heterogeneity of tumor cells and microenvironments for different pathological endometrial cancer and identiﬁes speciﬁc sensitive drugs","","Endometrial cancer (EC) shows marked heterogeneity in pathology and outcomes, while the heterogeneity of cancer cells and the tumor microenvironment (TME) remains insufficiently understood. Using single-cell RNA sequencing on 18 EC samples, distinct transcriptional landscapes were delineated across tumor pathological types, and sensitive therapeutic drugs were inferred and validated with patient-derived organoids. Favorable immune subtypes dominated normal endometrium, whereas distinct TME cell programs, including CXCL3+ macrophages and SOD2+ iCAFs/eCAFs, characterized tumors and suggested prognostic relevance.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/single-cell-transcriptome-profiles-the-heterogeneity-of-tumor-cells-and-microenvironments-for-different-pathological-endometrial-cancer-and-identifies-specific-sensitive-drugs/339876/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/single-cell-transcriptome-profiles-the-heterogeneity-of-tumor-cells-and-microenvironments-for-different-pathological-endometrial-cancer-and-identifies-specific-sensitive-drugs/339876.png","ImageObject",300,407,{"name":92,"@type":93},"Ezra","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main approach used to study endometrial cancer heterogeneity?","Question",{"text":112,"@type":113},"The study performed single-cell RNA sequencing (scRNA-seq) on 18 endometrial cancer samples spanning different pathological types, then analyzed distinct transcriptional landscapes and related TME features.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did the immune cell landscape differ between normal endometrium and tumors?",{"text":117,"@type":113},"Prognostically favorable CD8+ Tcyto and NK cells were prominent in normal endometrium, whereas CD4+ Treg, CD4+ Tex, and CD8+ Tex cells dominated tumor tissues.",{"name":119,"@type":110,"acceptedAnswer":120},"How were potential sensitive drugs evaluated in the pathological groups?",{"text":121,"@type":113},"Potential effective drugs were identified and their effectiveness was confirmed using patient-derived EC organoids for each pathological group, supporting the inferred sensitivities.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},339876,1790192900,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},1099514068035,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","[www.nature.com/cddis](www.nature.com/cddis)  \nARTICLE OPEN   \nSingle-cell transcriptome proﬁles the heterogeneity of tumor cells and microenvironments for different pathological endometrial cancer and identiﬁes speciﬁc sensitive drugs  \nFang Ren 1,5 ✉, Lingfang Wang2,5, Yuyouye Wang 1,5, Jiaxuan Wang1, Yuanpei Wang 1, Xiaole Song1, Gong Zhang3, Fangfang Nie 1 and Shitong Lin 1,4 ✉  \n© The Author(s) 2024  \n|  |  |  |\n| --- | --- | --- |\n|  | Endometrial cancer (EC) is a highly heterogeneous malignancy characterized by varied pathology and prognoses, and the heterogeneity of its cancer cells and the tumor microenvironment (TME) remains poorly understood. We conducted single-cell RNA sequencing (scRNA-seq) on 18 EC samples, encompassing various pathological types to delineate their speciﬁc unique transcriptional landscapes. Cancer cells from diverse pathological sources displayed distinct hallmarks labeled as immunemodulating, proliferation-modulating, and metabolism-modulating cancer cells in uterine clear cell carcinomas (UCCC), welldifferentiated endometrioid endometrial carcinomas (EEC-I), and uterine serous carcinomas (USC), respectively. Cancer cells from the UCCC exhibited the greatest heterogeneity. We also identiﬁed potential effective drugs and conﬁrmed their effectiveness using patient-derived EC organoids for each pathological group. Regarding the TME, we observed that prognostically favorable CD8+ Tcyto and NK cells were prominent in normal endometrium, whereas CD4+ Treg, CD4+ Tex, and CD8+ Tex cells dominated the tumors. CXCL3+ macrophages associated with M2 signature and angiogenesis were exclusively found in tumors. Prognostically relevant epithelium-speciﬁc cancer-associated ﬁbroblasts (eCAFs) and SOD2+ inﬂammatory CAFs (iCAFs) predominated in EEC-I and UCCC groups, respectively. We also validated the oncogenic effects of SOD2+ iCAFs in vitro. Our comprehensive study has yielded |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n| deeper insights into the pathogenesis of EC, potentially facilitating personalized treatments for its varied pathological types. |  |  |\n|  | Cell Death and Disease (2024)15:571; [https://doi.org/10.1038/s41419-024-06960-8](https://doi.org/10.1038/s41419-024-06960-8) |  |\n|  |  |  |\n\nINTRODUCTION  \nUterine corpus cancer ranks as the sixth most prevalent malignancy among women, with 417,000 new cases and 97,000 deaths reported in 2020 . The incidence rate of endometrial cancer (EC) has increased by 132% over the past three decades, a rise that mirrors the growing prevalence of risk factors, notably obesity and an aging population [1] . Traditionally, according to Bokhman et al.(1983), EC is classiﬁed into Type I (moderately to welldifferentiated EEC) and Type II based on clinical-pathological characteristics and prognosis, which includes poorly differentiated EEC (EEC-II), uterine serous carcinomas (USC), uterine clear cell carcinomas (UCCC), and uterine carcinosarcoma [2] . Our research, alongside other studies, has uncovered signiﬁcant variations in epidemiological characteristics, clinical parameters and prognosis among EC samples of different pathological types [3–5] . In stark contrast to the moderate or well-differentiated EEC (85%), the 5-year survival rates for USC (45.9%), uterine carcinosarcoma (53.6%), and UCCC (63%) are notably lower, reﬂecting their aggressive behavior, such as cervical involvement, peritoneal and  \nlymph-node metastasis, or distant organ metastasis [6, 7] . Currently, according to the National Comprehensive Cancer Network (NCCN) guidelines, there is no speciﬁc or effective treatment available to enhance prognosis by addressing such aggressive behavior [8] . Immunotherapy brings a glimmer of hope for treating malignant tumors, and the Food and Drug Administration (FDA) has approved pembrolizumab and Dostarlimab-gxly for advanced or recurrent EC in 2017 and 2021, respectively [9, 10] ","cbCaioGIwBc71GGv","https://ap.wps.com/l/cbCaioGIwBc71GGv","pdf",15073895,"English","# Introduction\n## EC heterogeneity and clinical outcomes\n## Limitations of current treatments\n## Genomic mutations across pathological types\n# Study approach and key findings\n## Single-cell RNA-seq across EC pathological groups\n## Immune and stromal components in TME\n## Drug sensitivity validation with organoids","[{\"question\":\"What was the main approach used to study endometrial cancer heterogeneity?\",\"answer\":\"The study performed single-cell RNA sequencing (scRNA-seq) on 18 endometrial cancer samples spanning different pathological types, then analyzed distinct transcriptional landscapes and related TME features.\"},{\"question\":\"How did the immune cell landscape differ between normal endometrium and tumors?\",\"answer\":\"Prognostically favorable CD8+ Tcyto and NK cells were prominent in normal endometrium, whereas CD4+ Treg, CD4+ Tex, and CD8+ Tex cells dominated tumor tissues.\"},{\"question\":\"How were potential sensitive drugs evaluated in the pathological groups?\",\"answer\":\"Potential effective drugs were identified and their effectiveness was confirmed using patient-derived EC organoids for each pathological group, supporting the inferred sensitivities.\"}]","Single-cell transcriptome proﬁles the heterogeneity of tumor cells and microenvironments for different pathological endometrial cancer and identiﬁes speciﬁc sensitive drugs | PDF",1790032883,48,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/433dfe4396846fd43e545b518615369c.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/65e86e5eb4d5e698312d1010b658fed8.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/623ea681d0d6be7e85268d8817fc5389.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cacb59a5fe4c77da2acb1000f2ef7ba9.webp",980,1301]